Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Biological Psychiatry
|
January 1, 1970
Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients
F M Forrest, I S Forrest, M T Serra
Proceedings of the Western Pharmacology Society
|
January 1, 1975
Chlorpromazine metabolism and excretion
I S Forrest, D E Green, M T Serra
The Biochemical Journal
|
April 1, 1972
The control of glycerol utilization by glucose metabolism
W Edgar, I S Forrest, W H Holms, et al.
The Journal of Pharmacy and Pharmacology
|
September 1, 1971
Interference of chemoluminescence with ( 3 H)scintillation counting
I S Forrest, L G Brookes, G Fukayama, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1976
Losses of radioactivity from 3H- or 14C-chlorpromazine labels due to procedural artifacts
I S Forrest, D E Green, M T Serra, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1975
New approaches to assay of cannabinoids in biological extracts
K O Loeffler, D E Green, F C Chao, et al.
Biochemical Pharmacology
|
March 1, 1970
Rabbit as a model for chlorpromazine-induced hyperpigmentation of the skin
I S Forrest, J C Kosek, R C Aber, et al.
Psychopharmacology Communications
|
January 1, 1975
Chlorpromazine excretion in chronically dosed primates. I. Occurrence of a previously unreported class of chlorpromazine conjugates
I S Forrest, D E Green, M T Serra, et al.
Communications in Psychopharmacology
|
January 1, 1979
Studies on thioridazine and mesoridazine metabolism. I. Protein binding
I S Forrest, D E Green, A Blum, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1974
Total excretion of 3H-chlorpromazine and 3H-prochlorperazine in chronically dosed animals: balance sheet
I S Forrest, J Fox, D E Green, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Biological Psychiatry
|
January 1, 1970
Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients
F M Forrest, I S Forrest, M T Serra
Proceedings of the Western Pharmacology Society
|
January 1, 1975
Chlorpromazine metabolism and excretion
I S Forrest, D E Green, M T Serra
The Biochemical Journal
|
April 1, 1972
The control of glycerol utilization by glucose metabolism
W Edgar, I S Forrest, W H Holms, et al.
The Journal of Pharmacy and Pharmacology
|
September 1, 1971
Interference of chemoluminescence with ( 3 H)scintillation counting
I S Forrest, L G Brookes, G Fukayama, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1976
Losses of radioactivity from 3H- or 14C-chlorpromazine labels due to procedural artifacts
I S Forrest, D E Green, M T Serra, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1975
New approaches to assay of cannabinoids in biological extracts
K O Loeffler, D E Green, F C Chao, et al.
Biochemical Pharmacology
|
March 1, 1970
Rabbit as a model for chlorpromazine-induced hyperpigmentation of the skin
I S Forrest, J C Kosek, R C Aber, et al.
Psychopharmacology Communications
|
January 1, 1975
Chlorpromazine excretion in chronically dosed primates. I. Occurrence of a previously unreported class of chlorpromazine conjugates
I S Forrest, D E Green, M T Serra, et al.
Communications in Psychopharmacology
|
January 1, 1979
Studies on thioridazine and mesoridazine metabolism. I. Protein binding
I S Forrest, D E Green, A Blum, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1974
Total excretion of 3H-chlorpromazine and 3H-prochlorperazine in chronically dosed animals: balance sheet
I S Forrest, J Fox, D E Green, et al.
Page
of 3